Impact of medicare readmissions penalties on targeted surgical conditions

Health Affairs

Volumn 38, Issue 7, 2019, Pages 1207-1215

  Chhabra, Karan R ^a,b   Ibrahim, Andrew M ^a,c   Thumma, Jyothi R ^a   Ryan, Andrew M ^a,b   Dimick, Justin B ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^c HOK Architects   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; HIP; HOSPITAL READMISSION; HUMAN; KNEE REPLACEMENT; LENGTH OF STAY; MEDICARE; PUNISHMENT; RISK ASSESSMENT; SURGICAL PATIENT; ECONOMICS; FEMALE; HIP REPLACEMENT; HOSPITAL; INSURANCE; MALE; REIMBURSEMENT; UNITED STATES;

ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; FEMALE; HOSPITALS; HUMANS; INSURANCE CLAIM REVIEW; MALE; MEDICARE; PATIENT READMISSION; REIMBURSEMENT, INCENTIVE; UNITED STATES;

EID: 85069267893     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.2019.00096     Document Type: Article

References (33)

1. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009; 360(14):1418-28.
2. Tsai TC, Joynt KE, Orav EJ, Gawande AA, Jha AK. Variation in surgicalreadmission rates and quality of hospital care. N Engl J Med. 2013; 369(12):1134-42.
3. Morris MS, Deierhoi RJ, Richman JS, Altom LK, Hawn MT. The relationship between timing of surgical complications and hospital readmission. JAMA Surg. 2014;149(4):348-54.
4. Dimick JB, Ghaferi AA. Hospital readmission as a quality measure in surgery. JAMA. 2015;313(5):512-3.
5. CMS.gov. Hospital Readmissions Reduction Program (HRRP) archives [Internet]. Baltimore (MD): Centers for Medicare and Medicaid Services; [last modified 2018 Nov 28; cited 2019 May 8]. Available from:https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/HRRPArchives. html
6. Ibrahim AM, Nathan H, Thumma JR, Dimick JB. Impact of the Hospital Readmission Reduction Program on surgical readmissions among Medicare beneficiaries. Ann Surg. 2017; 266(4):617-24.
7. Zuckerman RB, Sheingold SH, Orav EJ, Ruhter J, Epstein AM. Readmissions, observation, and the Hospital Readmissions Reduction Program. N Engl J Med. 2016;374(16):1543-51.
8. Mehtsun WT, Papanicolas I, Zheng J, Orav EJ, Lillemoe KD, Jha AK. National trends in readmission following inpatient surgery in the Hospital Readmissions Reduction Program era. Ann Surg. 2018; 267(4):599-605.
9. Miller DC, Gust C, Dimick JB, Birkmeyer N, Skinner J, Birkmeyer JD. Large variations in Medicare payments for surgery highlight savings potential from bundled payment programs. Health Aff (Millwood). 2011;30(11):2107-15.
10. Ibrahim AM, Dimick JB, Sinha SS, Hollingsworth JM, Nuliyalu U, Ryan AM. Association of coded severity with readmission reduction after the Hospital Readmissions Reduction Program. JAMA Intern Med. 2018; 178(2):290-2.
11. CMS.gov. 2017 ICD-10 PCS and GEMs [Internet]. Baltimore (MD):Centers for Medicare and Medicaid Services; [last modified 2016 Aug 22; cited 2019 May 8]. Available from:https://www.cms.gov/Medicare/Coding/ICD10/2017-ICD-10-PCSand-GEMs.html
12. Centers for Medicare and Medicaid Services. Hospital Quality Initiative, measure methodology. Baltimore (MD): CMS.
13. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8-27.
14. Southern DA, Quan H, Ghali WA. Comparison of the Elixhauser and Charlson/Deyo methods of comorbidity measurement in administrative data. Med Care. 2004;42(4):355-60.
15. Ody C, Msall L, Dafny LS, Grabowski DC, Cutler DM. Decreases in readmissions credited to Medicare’s program to reduce hospital readmissions have been overstated. Health Aff (Millwood). 2019; 38(1):36-43.
16. Birkmeyer JD, Gust C, Dimick JB, Birkmeyer NJ, Skinner JS. Hospital quality and the cost of inpatient surgery in the United States. Ann Surg. 2012;255(1):1-5.
17. Gottlieb DJ, Zhou W, Song Y, Andrews KG, Skinner JS, Sutherland JM. Prices don’t drive regional Medicare spending variations. Health Aff (Millwood). 2010;29(3):537-43.
18. Wright S. Memorandum report:hospitals’ use of observation stays and short inpatient stays for Medicare beneficiaries [Internet]. Washington (DC): Department of Health and Human Services, Office of Inspector General; 2013 [cited 2019 May 8]. (Pub. No. OEI-02-12-00040). Available from: https://oig.hhs.gov/oei/reports/oei-02-12-00040.pdf
19. Kontopantelis E, Doran T, Springate DA, Buchan I, Reeves D. Regression based quasi-experimental approach when randomisation is not an option:interrupted time series analysis. BMJ. 2015;350:h2750.
20. Wadhera RK, Joynt Maddox KE, Wasfy JH, Haneuse S, Shen C, Yeh RW. Association of the Hospital Readmissions Reduction Program with mortality among Medicare beneficiaries hospitalized for heart failure, acute myocardial infarction, and pneumonia. JAMA. 2018;320(24):2542-52.
21. Berstock JR, Beswick AD, Lenguerrand E, Whitehouse MR, Blom AW. Mortality after total hip replacement surgery: a systematic review. Bone Joint Res. 2014;3(6):175-82.
22. Desai NR, Ross JS, Kwon JY, Herrin J, Dharmarajan K, Bernheim SM, et al. Association between hospital penalty status under the Hospital Readmission Reduction Program and readmission rates for target and nontarget conditions. JAMA. 2016;316(24):2647-56.
23. Chaiyachati KH, Qi M, Werner RM. Changes to racial disparities in readmission rates after Medicare’s Hospital Readmissions Reduction Program within safety-net and non- safety-net hospitals. JAMA Netw Open. 2018;1(7):e184154.
24. Joynt KE, Figueroa JE, Oray J, Jha AK. Opinions on the Hospital Readmission Reduction Program: results of a national survey of hospital leaders. Am J Manag Care. 2016; 22(8):e287-94.
25. Gupta A. Impacts of performance pay for hospitals: the readmissions reduction program. Chicago (IL):Becker Friedman Institute for Research in Economics; 2017 Oct 16. (Working Paper No. 2017-07).
26. Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation. Report to Congress: social risk factors and performance under Medicare’s value-based purchasing programs [Internet]. Washington (DC): DHHS; 2016 Dec [cited 2019 May 8]. Available from: https://aspe.hhs.gov/system/files/pdf/253971/ASPESESRTCfull.pdf
27. Roberts ET, Zaslavsky AM, Barnett ML, Landon BE, Ding L, McWilliams JM. Assessment of the effect of adjustment for patient characteristics on hospital readmission rates: implications for pay for performance. JAMA Intern Med. 2018;178(11):1498-507.
28. Tsai TC, Orav EJ, Joynt KE. Disparities in surgical 30-day readmission rates for Medicare beneficiaries by race and site of care. Ann Surg. 2014;259(6):1086-90.
29. Dharmarajan K, Wang Y, Lin Z, Normand ST, Ross JS, Horwitz LI, et al. Association of changing hospital readmission rates with mortality rates after hospital discharge. JAMA. 2017;318(3):270-8.
30. Gupta A, Allen LA, Bhatt DL, Cox M, DeVore AD, Heidenreich PA, et al. Association of the Hospital Readmissions Reduction Program implementation with readmission and mortality outcomes in heart failure. JAMA Cardiol. 2018;3(1):44-53.
31. Huckfeldt P, Escarce J, Wilcock A, Sood N, Rabideau B, Popescu I, et al. HF mortality trends under Medicare readmissions reduction program at penalized and nonpenalized hospitals. J Am Coll Cardiol. 2018;72(20):2539-40.
32. Kahn CN 3rd, Ault T, Potetz L, Walke T, Chambers JH, Burch S. Assessing Medicare’s hospital pay-forperformance programs and whether they are achieving their goals. Health Aff (Millwood). 2015;34(8):1281-8.
33. Barnett ML, Wilcock A, McWilliams JM, Epstein AM, Joynt Maddox KE, Orav EJ, et al. Two-year evaluation of mandatory bundled payments for joint replacement. N Engl J Med. 2019;380(3):252-62.